From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Electrotrichogenesis (ETG) involves the stimulation of hair follicles on the scalp with the electric charge of an electrostatic field.

Three studies are listed in the PubMed database relating to the technique.[1][2][3]

Electrotrichogenesis was approved in Europe with the CE mark, as a medical device. It was also approved by Health Canada and the Australian health office.[citation needed]


  1. ^ Maddin, W. Stuart; Bell, Peter W.; James, John H. M. (1990). "The Biological Effects of a Pulsed Electrostatic Field with Specific Reference to Hair Electrotrichogenesis". International Journal of Dermatology. 29 (6): 446–450. doi:10.1111/j.1365-4362.1990.tb03837.x. PMID 2397975.
  2. ^ Benjamin, Benji; Ziginskas, Danute; Harman, John; Meakin, Timothy (2002). "Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: A pilot study". Psycho-Oncology. 11 (3): 244–248. doi:10.1002/pon.593. PMID 12112485.
  3. ^ Maddin, WS; Amara, I; Sollecito, WA (1992). "Electrotrichogenesis: further evidence of efficacy and safety on extended use". International Journal of Dermatology. 31 (12): 878–80. doi:10.1111/j.1365-4362.1992.tb03550.x. PMID 1478771.

Further reading[edit]

External links[edit]

  • Reuters news info on Current Technology Corporation, a company that offers electrotrichogenesis treatments.